A coxib a day won't keep the doctor away

This publication has 18 references indexed in Scilit:

• Therapeutic Arthritis Research and Gastrointestinal Event Trial of lumiracoxib – study design and patient demographics
  Alimentary Pharmacology & Therapeutics, 2004
• Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults
  Circulation, 2004
• Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study
  The Lancet, 2004
• Nonsteroidal Anti-Inflammatory drugs and cardiovascular risk
  Journal of the American College of Cardiology, 2004
• COX-2 and beyond: approaches to prostaglandin inhibition in human disease
  Nature Reviews Drug Discovery, 2003
• Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritis
  The American Journal of Cardiology, 2002
• Risk of Cardiovascular Events Associated With Selective COX-2 Inhibitors
  JAMA, 2001
• Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000